Class II
Ongoing
Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc.
Why: CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
- Company
- Hikma Pharmaceuticals USA INC.
Columbus, OH, United States - Reported
- Nov 11, 2026
- Recall started
- Oct 20, 2026
- Where sold
- US Nationwide
- Amount
- 29,085 bottles
- Full product description
- Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9928-01
- Lots / codes affected
- Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/2026
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.